ArticleNeuropsychiatric disease and treatment2019

Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population.

Adam J Savitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.